Cargando…

The biology and type I/III hybrid nature of type I-D CRISPR–Cas systems

Prokaryotes have adaptive defence mechanisms that protect them from mobile genetic elements and viral infection. One defence mechanism is called CRISPR–Cas (clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins). There are six different types of CRISPR–Cas systems...

Descripción completa

Detalles Bibliográficos
Autores principales:	McBride, Tess M., Cameron, Shaharn C., Fineran, Peter C., Fagerlund, Robert D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2023
Materias:	Biotechnology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10212523/ https://www.ncbi.nlm.nih.gov/pubmed/37052300 http://dx.doi.org/10.1042/BCJ20220073

Ejemplares similares

Structural rearrangements allow nucleic acid discrimination by type I-D Cascade
por: Schwartz, Evan A., et al.
Publicado: (2022)

Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems
por: Silas, Sukrit, et al.
Publicado: (2017)

Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering
por: Zheng, Yanli, et al.
Publicado: (2020)

Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems
por: Silas, Sukrit, et al.
Publicado: (2018)

Type I CRISPR-Cas provides robust immunity but incomplete attenuation of phage-induced cellular stress
por: Malone, Lucia M, et al.
Publicado: (2021)

Harnessing Type I and Type III CRISPR-Cas systems for genome editing
por: Li, Yingjun, et al.
Publicado: (2016)

Targeting of temperate phages drives loss of type I CRISPR-Cas systems
por: Rollie, Clare, et al.
Publicado: (2020)

DNA targeting by subtype I-D CRISPR–Cas shows type I and type III features
por: Lin, Jinzhong, et al.
Publicado: (2020)

Type III CRISPR-Cas complexes act as protein-assisted ribozymes during target RNA cleavage
por: Schwartz, Evan A., et al.
Publicado: (2023)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Regulation of the Type I-F CRISPR-Cas system by CRP-cAMP and GalM controls spacer acquisition and interference
por: Patterson, Adrian G., et al.
Publicado: (2015)

Type I-F CRISPR-Cas resistance against virulent phages results in abortive infection and provides population-level immunity
por: Watson, Bridget N. J., et al.
Publicado: (2019)

The role of Cas8 in type I CRISPR interference
por: Cass, Simon D.B., et al.
Publicado: (2015)

Bacteriophages suppress CRISPR–Cas immunity using RNA-based anti-CRISPRs
por: Camara-Wilpert, Sarah, et al.
Publicado: (2023)

In Vivo Protein Interactions and Complex Formation in the Pectobacterium atrosepticum Subtype I-F CRISPR/Cas System
por: Richter, Corinna, et al.
Publicado: (2012)

DNA targeting by the type I-G and type I-A CRISPR–Cas systems of Pyrococcus furiosus
por: Elmore, Joshua, et al.
Publicado: (2015)

Repurposing the atypical type I-G CRISPR system for bacterial genome engineering
por: Shangguan, Qilin, et al.
Publicado: (2023)

Types I and V Anti-CRISPR Proteins: From Phage Defense to Eukaryotic Synthetic Gene Circuits
por: Yu, Lifang, et al.
Publicado: (2020)

Priming in the Type I-F CRISPR-Cas system triggers strand-independent spacer acquisition, bi-directionally from the primed protospacer
por: Richter, Corinna, et al.
Publicado: (2014)

The application of CRISPR /Cas mediated gene editing in synthetic biology: Challenges and optimizations
por: Li, Wenqian, et al.
Publicado: (2022)

Uricase-deficient rat is generated with CRISPR/Cas9 technique
por: Yu, Yun, et al.
Publicado: (2020)

CaSilico: A versatile CRISPR package for in silico CRISPR RNA designing for Cas12, Cas13, and Cas14
por: Asadbeigi, Adnan, et al.
Publicado: (2022)

Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells
por: Pickar-Oliver, Adrian, et al.
Publicado: (2019)

Function and Application of the CRISPR-Cas System in the Plant Pathogen Erwinia amylovora
por: Parcey, Michael, et al.
Publicado: (2022)

Development of both type I–B and type II CRISPR/Cas genome editing systems in the cellulolytic bacterium Clostridium thermocellum
por: Walker, Julie E., et al.
Publicado: (2019)

Programmable type III-A CRISPR-Cas DNA targeting modules
por: Ichikawa, H. Travis, et al.
Publicado: (2017)

An Active Type I-E CRISPR-Cas System Identified in Streptomyces avermitilis
por: Qiu, Yi, et al.
Publicado: (2016)

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression
por: Luo, Michelle L., et al.
Publicado: (2015)

Type I-F CRISPR-Cas Distribution and Array Dynamics in Legionella pneumophila
por: Deecker, Shayna R., et al.
Publicado: (2020)

Recent Advances of CRISPR/Cas9-Based Genetic Engineering and Transcriptional Regulation in Industrial Biology
por: Zhang, Shangjie, et al.
Publicado: (2020)

A Global Comprehensive Study of the Distribution of Type I-E and Type I-E* CRISPR-Cas Systems in Klebsiella pneumoniae
por: Kannadasan, Anand Babu, et al.
Publicado: (2023)

Development and Application of CRISPR/Cas in Microbial Biotechnology
por: Ding, Wentao, et al.
Publicado: (2020)

CRISPR/Cas Technologies and Their Applications in Escherichia coli
por: Dong, Huina, et al.
Publicado: (2021)

Function and Regulation of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / CRISPR Associated (Cas) Systems
por: Richter, Corinna, et al.
Publicado: (2012)

Detection and characterization of spacer integration intermediates in type I-E CRISPR–Cas system
por: Arslan, Zihni, et al.
Publicado: (2014)

Modulating the Cascade architecture of a minimal Type I-F CRISPR-Cas system
por: Gleditzsch, Daniel, et al.
Publicado: (2016)

Adaptation induced by self-targeting in a type I-B CRISPR-Cas system
por: Stachler, Aris-Edda, et al.
Publicado: (2020)

Type I-F CRISPR–Cas provides protection from DNA, but not RNA phages
por: Buyukyoruk, Murat, et al.
Publicado: (2019)

Type I-E CRISPR-Cas System as a Defense System in Saccharomyces cerevisiae
por: Bindal, Gargi, et al.
Publicado: (2022)

Insight into the molecular mechanism of the transposon-encoded type I-F CRISPR-Cas system
por: Alalmaie, Amnah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3cr7oavpodpicl8fslcono3v5f